Publications: Aung-Htut, May

2022

Huang, D., Thompson, J.A., Chen, S-C, Adams, A., Pitout, I., Lima, A., Zhang, D., Jeffery, R.C.H., Attia, M.S., McLaren, T.L., Lamey, T.M., De Roach, J.N., McLenachan, S., Aung-Htut, M.T., Fletcher, S., Wilton, S.D. and Chen, F.K. (2022) Characterising splicing defects of ABCA4 variants within exons 13–50 in patient-derived fibroblasts. Experimental Eye Research, 225 . Art. 109276.

Ham, K.A.ORCID: 0000-0002-7036-5334, Wilton, S.D. and Aung-Htut, M.T. (2022) Nonsequential Pre-mRNA Splicing: From basic understanding to impacts on Splice-Manipulating therapies. In: Jurga, S. and Barciszewski, J., (eds.) Messenger RNA Therapeutics. Springer, pp. 429-446.

Zaw, K.ORCID: 0000-0002-4121-1985, Carvalho, L.S., Aung-Htut, M.T., Fletcher, S., Wilton, S.D., Chen, F.K. and McLenachan, S. (2022) Pathogenesis and Treatment of Usher Syndrome Type IIA. Asia-Pacific Journal of Ophthalmology, 11 (4). pp. 369-379.

Flynn, L.L., Li, R., Pitout, I.L., Aung-Htut, M.T., Larcher, L.M., Cooper, J.A.L., Greer, K.L., Hubbard, A., Griffiths, L., Bond, C.S., Wilton, S.D., Fox, A.H. and Fletcher, S. (2022) Single stranded fully Modified-Phosphorothioate oligonucleotides can induce structured nuclear inclusions, alter nuclear protein localization and disturb the transcriptome In Vitro. Frontiers in Genetics, 13 . Art. 791416.

2021

Li, D., McIntosh, C.S., Mastaglia, F.L., Wilton, S.D. and Aung-Htut, M.T. (2021) Correction to: Neurodegenerative diseases: A hotbed for splicing defects and the potential therapies. Translational Neurodegeneration, 10 (1). Art. 41.

Ham, K.ORCID: 0000-0002-7036-5334, Keegan, N., McIntosh, C., Aung-Htut, M., Zaw, K.ORCID: 0000-0002-4121-1985, Greer, K., Fletcher, S. and Wilton, S. (2021) Cryptic U2-dependent pre-mRNASplice site usage induced by splice switching antisense oligonucleotides. Research Square . In Review.

Huang, D., Zhang, D., Chen, S-C, Aung-Htut, M.T., Lamey, T.M., Thompson, J.A., McLaren, T.L., De Roach, J.N., Fletcher, S., Wilton, S.D., Chen, F.K. and McLenachan, S. (2021) Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene. Stem Cell Research, 54 . Art. 102448.

Ham, K.A.ORCID: 0000-0002-7036-5334, Keegan, N.P., McIntosh, C.S., Aung-Htut, M.T., Zaw, K.ORCID: 0000-0002-4121-1985, Greer, K., Fletcher, S. and Wilton, S.D. (2021) Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides. Scientific Reports, 11 (1). Article 15137.

Li, D., McIntosh, C.S., Mastaglia, F.L., Wilton, S.D. and Aung-Htut, M.T. (2021) Neurodegenerative diseases: A hotbed for splicing defects and the potential therapies. Translational Neurodegeneration, 10 (1). Art. 16.

McIntosh, C.S., Li, D., Wilton, S.D. and Aung-Htut, M.T. (2021) Polyglutamine ataxias: Our current molecular understanding and what the future holds for antisense therapies. Biomedicines, 9 (11). Article 1499.

McIntosh, C.S., Watts, G.F., Wilton, S.D. and Aung-Htut, M.T. (2021) Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations. Current Opinion in Lipidology, 32 (6). pp. 355-362.

Huang, D., Heath Jeffery, R.C., Aung-Htut, M.T., McLenachan, S., Fletcher, S., Wilton, S.D. and Chen, F.K. (2021) Stargardt disease and progress in therapeutic strategies. Ophthalmic Genetics . ahead-of-print.

Huang, D., Thompson, J.A., McLenachan, S., Chen, S-C, Zhang, D., Heath Jeffery, R.C., Attia, M., McLaren, T.L., Lamey, T.M., De Roach, J.N., Aung-Htut, M.T., Adams, A., Fletcher, S., Wilton, S. and Chen, F.K. (2021) Using induced pluripotent stem cell-derived retinal pigment epithelial cells to model splicing defects of ABCA4 c.5461-10T > C detected in an Australian Stargardt disease cohort. Investigative Ophthalmology and Visual Science, 62 (8). Art. 3294.

2020

Ham, K.A.ORCID: 0000-0002-7036-5334, Aung-Htut, M.T., Fletcher, S. and Wilton, S.D. (2020) Nonsequential splicing events alter antisense-mediated exon skipping outcome in COL7A1. International Journal of Molecular Sciences, 21 (20). Article 7705.

Aung-Htut, M.T., Ham, K.A.ORCID: 0000-0002-7036-5334, Tchan, M.C., Fletcher, S. and Wilton, S.D. (2020) Novel mutations found in individuals with adult-onset Pompe disease. Genes, 11 (2). Article 135.

Aung-Htut, M.T., Ham, K.A.ORCID: 0000-0002-7036-5334, Tchan, M., Johnsen, R., Schnell, F.J., Fletcher, S. and Wilton, S.D. (2020) Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease. Scientific Reports, 10 . Article number: 6702.

Li, D., Aung-Htut, M.T., Ham, K.A.ORCID: 0000-0002-7036-5334, Fletcher, S. and Wilton, S.D. (2020) A splice intervention therapy for autosomal recessive juvenile Parkinson’s disease arising from Parkin mutations. International Journal of Molecular Sciences, 21 (19). Article 7282.

2019

Zaw, K.ORCID: 0000-0002-4121-1985, Greer, K., Aung-Htut, M.T., Mitrpant, C., Veedu, R.N., Fletcher, S. and Wilton, S.D. (2019) Consequences of making the inactive active through changes in antisense oligonucleotide chemistries. Frontiers in Genetics, 10 . Article 1249.

Aung-Htut, M.T., McIntosh, C.S., West, K.A.ORCID: 0000-0002-7036-5334, Fletcher, S. and Wilton, S.D. (2019) In vitro validation of phosphorodiamidate morpholino oligomers. Molecules, 24 (16). Article 2922.

Aung-Htut, M.T., Comerford, I., Johnsen, R., Foyle, K., Fletcher, S. and Wilton, S.D. (2019) Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides. Scientific Reports, 9 (1).

McIntosh, C.S., Aung-Htut, M.T., Fletcher, S. and Wilton, S.D. (2019) Removal of the polyglutamine repeat of ataxin-3 by redirecting pre-mRNA processing. International Journal of Molecular Sciences, 20 (21). Article 5434.

Aung-Htut, M.T., McIntosh, C.S., Ham, K.A.ORCID: 0000-0002-7036-5334, Pitout, I.L., Flynn, L.L., Greer, K., Fletcher, S. and Wilton, S.D. (2019) Systematic approach to developing splice modulating antisense oligonucleotides. International Journal of Molecular Sciences, 20 (20). Article 5030.

2018

Aung-Htut, M.T., West, K.ORCID: 0000-0002-7036-5334, Barrett, L., Cardwell, K., Schnell, F.J., Fletcher, S. and Wilton, S.D. (2018) Late onset Pompe disease: Rescue of acid alpha-glucosidase expression by splice modification. Journal of Gene Medicine, 20 (1).

McIntosh, C.S., Aung-Htut, M.T., Fletcher, S. and Wilton, S.D. (2018) The use of antisense oligonucleotide-mediated exon skipping to treat spinocerebellar ataxia type 3. Journal of Gene Medicine, 20 (1).

2017

Chakravarthy, M., Aung-Htut, M.T., Le, B.T. and Veedu, R.N. (2017) Novel Chemically-modified DNAzyme targeting Integrin alpha-4 RNA transcript as a potential molecule to reduce inflammation in multiple sclerosis. Scientific Reports, 7 (1).

2016

Fraidenraich, D., Toh, Z.Y.C., Aung-Htut, M.T., Pinniger, G., Adams, A.M., Krishnaswarmy, S., Wong, B.L., Fletcher, S. and Wilton, S.D. (2016) Deletion of dystrophin In-Frame Exon 5 leads to a severe phenotype: Guidance for Exon skipping strategies. PloS one, 11 (1). e0145620.

2015

Aung-Htut, M.T., Fletcher, S. and Wilton, S. (2015) Antisense oligonucleotides induced splice switching of FN1 transcript. The Journal of Gene Medicine, 17 (8 - 9). PO9.